Results 251 to 260 of about 113,231 (318)
Advanced extracellular vesicle immunotherapy
A diagrammatic depiction of the therapeutic applicability of extracellular vesicles (EVs) in immunotherapy. This review explores the dual roles of tumor‐derived and immune cell‐derived EVs in cancer immunotherapy, discusses recent progress in EV engineering that improve their clinical utility, and evaluates their potential to augment existing ...
Jingjing Zhang +6 more
wiley +1 more source
<i>Mycobacterium tuberculosis</i> fluorescent and bioluminescent imaging technologies: addressing the issue of sensitivity. [PDF]
Zangirolami AC +4 more
europepmc +1 more source
The key residue responsible for the red shift of bioluminescence spectra of light-sensitive Ca<sup>2+</sup>-regulated photoproteins of ctenophores. [PDF]
Burakova LP, Vysotski ES.
europepmc +1 more source
Molecular theranostics: principles, challenges and controversies
Molecular theranostics offers a powerful tool to drive precision medicine in nuclear oncology. While theranostics is not a new principle in nuclear medicine, recent advances in instrumentation and radiopharmacy have driven a reinvigoration and a broader suite of applications.
Geoffrey Currie
wiley +1 more source
Red-shifted d-luciferin analogues and their bioluminescence characteristics. [PDF]
Watthaisong P +16 more
europepmc +1 more source
RTA‐408 Enhances Radiosensitivity and Inhibited Tumor Progression via JNK Pathway in Glioblastoma
ABSTRACT Glioblastoma (GBM) is an aggressive brain tumor with poor prognosis owing to its high invasiveness and resistance to therapy. RTA‐408, a synthetic triterpenoid and nuclear factor erythroid 2‐related factor 2 activator, exhibits anti‐inflammatory and anti‐cancer properties; however, its effects on GBM remain unclear. This study investigated the
Hung‐Pei Tsai +6 more
wiley +1 more source
6-4 photolyase differentially modulates transcription in the vertebrate circadian clock. [PDF]
Li H +7 more
europepmc +1 more source

